Get started
Author

Toru Ebina

ORCID: 0009-0000-4341-9563
Observed ORCID: 0009-0000-4341-9563
OpenAlex ID: A5048802330
Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination
2023 · Takuto Tachita, Takenori Takahata, et al. · International Journal of Hematology · 11
PDF
Immunosuppressive Effects of Multiple Myeloma‐Derived Extracellular Vesicles Through T Cell Exhaustion
2025 · Shinya Hagiwara, Masaki Ri, et al. · Cancer Science · 10
PDF
Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma
2025 · Toru Ebina, Masaki Ri, et al. · Cancer Science · 3
PDF
Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution
2024 · Naohiro Matsunaga, Tomotaka Suzuki, et al. · Clinical Lymphoma Myeloma & Leukemia · 3
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma
2023 · Tomotaka Suzuki, Shigeru Kusumoto, et al. · International Journal of Hematology · 3
PDF
Trends in survival outcomes after allogeneic transplantation for MDS and MDS / MPN in a real‐world experience: A 25‐year nationwide study
2026 · Hidehiro Itonaga, Yasushi Miyazaki, et al. · British Journal of Haematology · 2
Prevalence of CCR7‐Positive CD8 T Cells as a Prognostic Factor in B‐Cell Maturation Antigen ‐Targeted Chimeric Antigen Receptor T Cell Therapy
2025 · Yoshiaki Marumo, Masaki Ri, et al. · eJHaem · 2
PDF
Prognostic Impact of Clinical Factors and Cell Composition of Apheresis Samples on BCMA CAR-T Cell Therapy for Relapsed or Refractory Multiple Myeloma
2024 · Yoshiaki Marumo, Masaki Ri, et al. · Blood · 2
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia
2023 · Tomotaka Suzuki, Shigeru Kusumoto, et al. · Cancer Medicine · 2
PDF
Cardiac Glycosides Induce Immunogenic Changes in Myeloma Cells and Enhance the Efficacy of Monoclonal and Bispecific Antibody Therapy
2024 · Tomoyuki Nakamura, Masaki Ri, et al. · Blood · 1
PDF
Effects of long-term cryopreservation at −80 °C on the viability and recovery of peripheral blood stem cells
2026 · Tomoaki Akagi, Toru Ebina, et al. · Hematology
PDF
Differential trends in survival after allogeneic transplantation for MDS and MDS/MPN in a real-world experience
2025 · Hidehiro Itonaga, Yasushi Miyazaki, et al. · Blood
PDF
Targeting Overexpressed IDO on Stromal Cells As a Potential Therapeutic Strategy in Multiple Myeloma
2024 · Toru Ebina, Masaki Ri, et al. · Blood
PDF
P65-1 Clinicopathological feature of T-cell lymphoma in our institute
2022 · Takenori Takahata, Takuto Tachita, et al. · Annals of Oncology
PDF
Works count: 14
Citation count: 39
H-index: 3
I10-index: 2
Year
Topic
Type